Klinika Oczna

Abstract

3/2022 vol. 124
Review paper

Focal therapies for retinoblastoma

  1. Klinika Okulistyki Instytutu „Pomnik – Centrum Zdrowia Dziecka” w Warszawie
    Department of Ophthalmology, Children’s Memorial Health Institute in Warsaw, Poland
KLINIKA OCZNA 2022, 124, 3:131-136
Online publish date: 2022/03/31
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Currently, the primary treatment for retinoblastoma is intravenous and/or intraarterial chemotherapy. However, adjuvant focal therapies are also an essential component in the treatment of this cancer. The article discusses the methods of focal treatment of retinoblastoma: cryotherapy, transpupillary laser thermotherapy, transpupillary laser thermotherapy with intravenous indocyanine, brachytherapy, enucleation, and intraarterial and bicameral injections of melphalan. Particular attention is given to the latest methods of treatment including topical chemotherapy (intravitreal injections) and intraarterial chemotherapy. These modern topical treatments help salvage the eye in an increasing number of patients with advanced retinoblastoma.
Share
without publication fees
without publication fees